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ABSTRACT: In order to combat the growing threat of
global infectious diseases, there is a need for rapid
diagnostic technologies that are sensitive and that can
provide species speciﬁc information (as might be needed to
direct therapy as resistant strains of microbes emerge).
Here, we present a convenient, enzyme-free ampliﬁcation
mechanism for a rational hybridization chain reaction,
which is implemented in a simple format for isothermal
ampliﬁcation and sensing, applied to the DNA-based
diagnosis of hepatitis B virus (HBV) in 54 patients. During
the cycled ampliﬁcation process, DNA monomers self-
assemble in an organized and controllable way only when a
speciﬁc target HBV sequence is present. This mechanism is
conﬁrmed using super-resolution stochastic optical reconstruction microscopy. The enabled format is designed in a
manner analogous to an enzyme-linked immunosorbent assay, generating colored products with distinct tonality and with
a limit of detection of ca. ﬁve copies/reaction. This routine assay also showed excellent sensitivity (>97%) in clinical
samples demonstrating the potential of this convenient, low cost, enzyme-free method for use in low resource settings.
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The sensitive and speciﬁc detection of nucleic acids isimportant in a wide range of clinical diagnosticanalyses. Although DNA biosensors have previously
been developed,1 currently their implementation often relies
on the enzymatic ampliﬁcation of the target DNA. This can be
achieved using either thermal cycling (e.g., polymer chain
reaction, PCR), isothermal ampliﬁcation methods, such as
loop-mediated isothermal ampliﬁcation (LAMP)2 or cross-
priming ampliﬁcation (CPA),3 for example. Many of these
enzyme-mediated assays have been constrained in their use,
requiring well-resourced settings with well-controlled environ-
mental conditions (for enzyme storage) as well as the need for
complex sample puriﬁcation steps (to avoid reaction inhibitors
present in samples).
To overcome these limitations, isothermal, enzyme-free
methods have been developed, based on speciﬁc DNA
hybridization, which amplify the biochemical signal.4 As a
general scheme, the presence of target DNA (from bacteria, for
example) leads to the opening of DNA hairpin structures to
create a chain reaction involving many hairpin openings,
resulting in multiple hybridizations. Such cascades lead to the
formation of a large DNA complex, which can then be easily
detected, either optically or using label-free sensing.5−9 This
chain reaction and, thus, the molecular weight/size of the
product (as the ampliﬁed signal) have proven to be diﬃcult to
control, limiting the opportunities to develop high sensitivity
and quantitative assays. Consequently, enzymatic mediated
methods, such as PCR, remain the gold standard for DNA
ampliﬁcation and sensing, providing quantitative and control-
lable ampliﬁcation, albeit in well-controlled environmental
conditions.10,11
We now show a diﬀerent class of HCR assay which
combines the advantages of controlled ampliﬁcation with
hybridization (as the fundamental principles of an enzyme-free
biochemical reaction) in order to develop a quantitative and
sensitive DNA ampliﬁcation technique. The technique is self-
limiting, as the ampliﬁcation is sustained only until reactants
become kinetically depleted.
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RESULTS AND DISCUSSION
Reaction Mechanism. The proposed rational HCR is
based on two primer dumbbell-shaped DNA (db DNA)
structures (U1 and U2), capable of binding to each other
stoichiometrically (one unit of each can bind to 4 units of the
other, Figure 1a), thus providing the potential for an
exponential growth. The primer dumbbells are formed by
two starting oligonucleotides (U1−1/U1−2 and U2−1/U2−
2) with a complementary nucleotide matching in their
midsequence (1/1c of U1 and 4/4c of U2). There are also
two exposed “sticky” ends, each complementary to the other
(e.g., 2 of U1 is complementary to 2c of U2). At each cycle,
one unit (e.g., U1) serves as the template for the hybridization
with a number of the other unit (e.g., U2). Once hybridization
is complete, the second unit (e.g., U2) is removed from the
reaction volume and replaced with the ﬁrst unit (e.g., U1),
which can then hybridize with the product of the previous
cycle.
The ampliﬁcation factor and, thus, the molecular weight of
the amplicon at each cycle are linked to the number of units
that can bind to the product of the previous cycle, between 1
and 4 (which is itself dependent on the concentration ratios
between the 2 units, Figure 1b). By analogy to the PCR cycle,
the rate of ampliﬁcation reaches a plateau as the concentration
of available primers for the reaction decreases, and the kinetics
of the reaction become rate-limiting.
We conﬁrmed the relationship between the molecular
weight of the amplicon after the ﬁrst cycle and the
stoichiometry ratios of the db DNA primers, using gel
electrophoresis. Figure 1b shows the db DNA units (U1 and
U2) alone (45 bp, lanes 1−2) and after having been mixed in a
ratio of 1:5 (lanes 3−4) and 1:20 (lanes 5−6). The reaction
forms stable structures with 2 db DNA and 3, 4, and 5 db DNA
together. As the stoichiometric ratio decreases, the amount of
the larger complexes increases at the expense of the smaller
ones. For example, the intensity of the band at 225 bp (5
dbDNA) is similar (unitary) to the band at 90 bp (2 dbDNA)
at a ratio of 1:5 but is much higher (double) at a ratio of 1:20.
Theoretically, the ﬁrst step of the reaction should proceed at
maximal eﬃciency (or coverage) with a ratio of 1:4, where all
U1 binds to 4 U2 (Figure 1a); however, due to mass transfer
and competing hybridizations, a range of constructs of diﬀerent
sizes are formed, while larger sizes are favored by smaller ratios.
In order to demonstrate that this rational HCR DNA
ampliﬁcation system forms large, packed DNA nanostructures
as predicted, we used a system where a single dumbbell DNA
structure can self-hybridize (Figure S1a) at the same
stoichiometry as that of the 2 db structure, i.e., at a ratio of
1:4. The product of this single db DNA-mediated HCR was
evaluated using gel electrophoresis (Figure S1b), showing
bands of increasing sizes, corresponding to increasing numbers
of unit db DNA bound together, as well as products with a
much larger size (as a smear).
Reaction Cycling. As discussed, the control of the rate of
reaction is dependent upon the stoichiometric ratio between
the two db DNA primers, one being in excess to the other, in
order to build a structure based on a 1:4 complex. To then
continue ampliﬁcation, this excess needs to be reversed. Here,
we show that this can be implemented conveniently through
the immobilization of the appropriate reagents on beads with a
Figure 1. Reaction principle of db DNA-based rational HCR. (a) Schematic illustration of synthesis and inter-reaction of db DNA units. Two
starting oligonucleotides (U1−1/U1−2 or U2−1/U2−2) possess the same sticky ends at 3′ and 5′ ends, as well as complementary
midsequence segments, as indicated. For the process starting from U1 (left), the db DNA units (U1 or U2) hybridize (step 1). Similarly, the
DNA synthesis process can also begin from U2 (right). The formed db DNA units (U2) can be combined to U1 during the rational HCR
process (step 2), due to their exposed complementary sticky ends. Thus, by addition of U2 and U1 successively and repeatedly, these two
units can bind to each other leading to an exponential growth of a packed complex 3D DNA structure (step n); (b) Evaluation of the product
of db DNA-based rational HCR using gel electrophoresis. L lane was 100 bp ladder, lane 1 and 2 were U1 and U2, Lanes 3 and 4 were the
hybridized products of U1 and U2 with stoichiometry ratio at 5:1 (and 1:5, respectively), and Lanes 5 and 6 were the product of
stoichiometry ratio at 20:1 (and 1:20, respectively), the unit with a low concentration was kept at 0.1 μM. Bands from 90 to 225 bp (from
lane 3 to 6) illustrate the expected products ratios, which are diﬀerent to those from the smallest units (lane 1/2). For this concentration of
single units, larger products are not formed eﬃciently (evidence of limited formation is shown by smears in the large sizes), since the single
units become depleted as the reaction progresses.
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simple washing step, implemented as cycles involving the
addition of one primer (followed by incubation, washing and
then addition of the second primer in a new cycle). At each
cycle, the number of exposed sticky ends created is 3 per
primer bound, the number of which is linked to the number of
sticky ends at the previous cycle. The size of the structure thus
scales in a controlled and well-deﬁned manner as 4 × 3n db
DNA primers, where n is the number of cycles (Figure S2).
The washing steps can be conveniently performed, using a
magnetic microbead solid support (Figure 2), taking advantage
of their high surface-to-volume ratio (as previously demon-
strated through the host of applications they have been used in,
such as biobarcode,12 DNA-based ﬂuorescence nanobarco-
des,13 and enzyme based optical nanoprobes).14 Here, we
attached a biotin-labeled DNA capture probe on the surface of
a microparticle through an avidin coupling as previously
described.13 The probe was complementary to a target DNA
sequence (the analyte to be detected), which was then bound
onto the bead. One sticky end of a db DNA primer was
designed to be complementary to the target DNA sequence,
such that it can initiate the ampliﬁcation reaction and hybridize
with the target DNA on the bead. The ﬁrst primer was washed
oﬀ and replaced by the second db DNA primer. Three
molecules hybridize to the ﬁrst primer, and the reaction can
then be cycled to achieve signal ampliﬁcation. To detect the
hybridization and thus the target DNA sequence, both primers
were labeled with the ﬂuorophore Cy5 at their 5′ stick ends
(two ﬂuorophore per primer). Theoretically (Figure 1a), the
number of ﬂuorophore in the construct thus should increase by
a factor 3n, potentially yielding a large signal for a small number
of target molecules bound toward single molecule detection.
To conﬁrm the mechanism proposed, we captured super-
resolution images of individual beads as the rational HCR
progresses. The number of captured ﬂuorescence-labeled db
DNA units on the surface of the microbeads increases (Figure
2a) for each cycle, leading to an exponential ampliﬁcation of
the ﬂuorescence signals that started from individual immobi-
lized targets as shown by the super-resolution images presented
and quantiﬁed in Figure 2b. The size of the ﬂuorescent
clusters, identiﬁed by segmentation (see Figure S4 for an
example of the process), increases as the beads are processed
through more cycles of hybridization and wash. By increasing
the target DNA concentration, the number of spots on each
bead can increase signiﬁcantly, indicating that each spotlike
feature represents the signal of a single event (Figure S3). The
signal can also be viewed using a normal ﬂuorescence
microscope (Figure S3).
Assay Format. As a practical demonstration, the detection
of the sensing events at such low concentrations using
ﬂuorescence is not feasible routinely, as it requires scanning
Figure 2. Microbead-based DNA detection: (a) Schematic drawing of db DNA-based rational HCR for signal ampliﬁcation of target DNA
from magnetic microbeads. Brieﬂy, biotin-labeled capture probes were immobilized onto avidin-functionalized microbeads. Target DNA was
then captured by these speciﬁc microbeads. The detection probe links to U1′ and is also complementary to a second part of the target DNA
and thus enabled U1 to bind to the surface of microbeads (see Table S1 for details). Fluorescence-labeled db DNA units were successively
added to amplify the signal, forming larger constructs as the reactions proceeds. A washing step is necessary after each hybridization step to
remove the excess db DNA units. (b) Fluorescence signal of microbeads at diﬀerent cycles, imaged by super-resolution stochastic optical
reconstruction microscopy (STORM) (the images’ contrast and brightness were modiﬁed for ease of presentation) and analyzed using
segmentation (see Figure S4 for an example of the process), showing the average area of a ﬂuorescent spot (measured in pixels) for at least
10 beads for each cycle of washing and addition of reagent. All beads are 5 μm in diameter.
Figure 3. Schematic representation of db DNA-based ELISA. The target DNA is anchored to the magnetic microparticles (MMPs) by the
biotin-labeled capture probes and then recognized and ampliﬁed by the biotin-labeled db DNA units. The enzyme is linked to the complex
through the interaction between enzyme-decorated avidin and biotin reaction.
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observation ﬁelds with high magniﬁcation to identify individual
ﬂuorescent beads. We thus adapted the signal ampliﬁcation
technique of enzyme-linked immunosorbent assays
(ELISA),14,15 where an avidin-labeled enzyme (horseradish
peroxidase, HRP, ca. 6 nm in diameter) was attached to a
biotin-db DNA primer (Figure 3). To avoid unspeciﬁc binding
of the enzyme onto the bead surface, this was only added at the
last cycle, at the end of the rational HCR. Two out of the three
sticky ends of the db DNA primer host a biotin moeity. After
cycle n, there are 4 × 3n sticky ends, yielding 8 × 3n−1 sites for
the immobilization of HRP, forming a densely packed HRP
complex on the surface of the microbeads. The result of db
DNA-based enzyme-linked HCR analysis was quantiﬁed on a
microplate reader (450 nm) or directly by the naked eye
(Figure 4), after the substrate (tetramethylbenzidine, TMB)
was added.
The observed response curve is analogous to that of a real-
time PCR assay, Figure 4a, with the signal increasing
exponentially with the number of cycles performed, until
kinetically depleted. We could deﬁne an equivalent cycle
threshold (Ct) of 9 when the signal reaches a level of intensity
higher than 3 standard deviation oﬀ the background. A linear
regression of the logarithm of the absorbance in the
exponential phase reveals a slope of 0.25 ± 0.03, which
would correspond to an ampliﬁcation factor of 1.28n−1 (as
opposed to 3n−1, predicted theoretically). We attribute this
limitation in eﬃciency to two main factors, namely the fact the
thermodynamic equilibrium of all DNA bound is kinetically
limited, leading to unbound DNA, as well as steric hindrance,
which limits DNA binding to available sites in complex, large
structures together with HRP labeling in the ﬁnal step.
The signal reached a plateau after cycle 16, when the
number of molecules added at the beginning of the cycle (free
db DNA primer 0.5 μM, ca. 1010 molecules) is of the same
order as that of sticky ends present on the beads (8 × 315, ca.
109), thus limiting the eﬃciency of the reaction (as discussed
in Figure 1b).
Analytical Performance. The analytical performance of
the assay, as shown in Figure 4c,d, shows a limit of detection of
ﬁve molecules in a 20 μL reaction after 35 cycles. Once
ampliﬁed, the signal was also detectable with the naked eye
(Figure 4c). Speciﬁcity was evaluated using an excess of
noncomplementary target DNA, which did not produce a
signiﬁcant absorption compared to speciﬁc target DNA (Figure
4e). Further, we also studied the ability of the assay to
eﬀectively discriminate a single-base mismatch in the target
DNA (Figure 4e). The technique relies on DNA hybridization,
and we observe behaviors similar to those of other techniques
based on the same principle, such as DNA microarrays.16 The
discrimination is not eﬀective when the defect is located at the
edges of the binding sequence, but the probe sequence can be
designed to yield a signal close to that of a noncognate DNA
and provide excellent mismatch discrimination, when the
defect is located in the middle of the sequence.
Contrary to DNA-based signal ampliﬁcation methods
developed previously, such as chemical cross-linked dendritic
DNA,16−18 DNA nanobarcodes,13,19 and backbone-branched
oligonucleotides,20−22 this rational HCR cycling method
harnesses the level of control of biochemical reactions that
has been instrumental in placing PCR as a gold standard
technique in molecular biology. The microbead-based assay
process is also simple and convenient, where analysis of a few
copies of target DNA can be performed visually, with the
naked eye, making it suitable for performing DNA-based
diagnostics.
Clinical Applicability. To demonstrate the applicability of
the technique in the clinic, we designed an assay to detect
hepatitis B virus (HBV) in patients. HBV is a major cause of
death worldwide (comparable to HIV and tuberculosis1.46
millions death in 2013).23 If the elimination targets (by 2030)
of the World Health Organization are to be met, better
approaches to reach underserved populations are to be
developed. In a group of 54, our cyclic HCR methodology
detected 37/38 infected patients (benchmarked against real-
time qPCR), missing only one patient in the cohort, who had a
low infection burden (<10 copies, see Figure 5 and data in the
Supporting Information). There was very good agreement with
Figure 4. Rational enzyme-linked HCR. (a) Photograph indicates the color changing with diﬀerent db DNA units addition times from 2 to
20 (cycles), respectively (left to right, target DNA concentration 5 pM), in a 96 microtiter plate. (b) Absorbance with respect to the blank
was monitored at 450 nm. Black square: target concentration 5 pM. Red disk: ddH2O as a negative control. Data are the average of at least
three replicates, and error bars represent the standard deviation. The data were ﬁtted with nonlinear curve ﬁtting to a Boltzmann curve (R2 >
0.98). (c) Analytical sensitivity. Color change with diﬀerent target DNA concentration from 0.5 copies to 5 × 105 copies/reaction (10×
increments per well) with the db DNA units addition times at 35 (cycles). The results are quantiﬁed in (d). Absorbance at 450 nm. Data are
the average of at least three replicates, and error bars represent the standard deviation. The signal increases until a plateau is reached after
5000 copies/reaction. The limit of detection is 5 copies/reaction. (e) 1 pM of diﬀerent target DNA molecules was added to the reaction:
perfect match DNA, single mismatch DNA with the defect located at diﬀerent position (toward the 5′ end, the 3′ end and in the middle
respectively), and noncognate DNA. The sequences are provided in Table S1. Data are the average of at least three replicates, and error bars
represent the standard deviation.
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rt-qPCR, on par with the best assays available; see also Figure
5.
CONCLUSIONS
In this work, we have designed and demonstrated a cyclic HCR
technique to detect DNA molecules using an enzyme-free
ampliﬁcation scheme. The control enabled by cycling the
reaction, akin to that available in PCR, led to high sensitivity
(ca. ﬁve copies). We also demonstrated the applicability of the
method in clinical study to detect HBV in the serum of
patients. The method could also in the future be used for single
molecule sensing by using electrochemical detection for HRP-
catalyzed reactions24 or super-resolution microscopy as
illustrated here. Furthermore, the db DNA primer units are
both eﬃcient structural scaﬀolds and functional molecules
which could be modiﬁed to develop proteomic and
metabolomic assays by replacing the target DNA with
aptamers.25
EXPERIMENTAL METHODS
Oligonucleotides Designs. The oligo sequences were designed
and tested for hybrids and hairpin structures using the Integrated
DNA Technologies design tools;26 sequence information can be
found in Table S1. The oligos were commercially synthesized, PAGE
puriﬁed (Euroﬁns, UK), and dissolved in TE buﬀer (10 mM Tris, 1
mM ethylenediaminetetraacetic acid (EDTA), pH = 8.0) to a ﬁnal
concentration of 100 μM. Two db DNA units were constructed by
mixing two speciﬁc oligonucleotide components (1:1 molar ratio) in
2× SSC buﬀer with a ﬁnal concentration of 2 μM for each
oligonucleotide. The hybridizations were performed as follows: (1)
denaturation at 95 °C for 5 min; (2) annealing at 50 °C for 10 min;
(3) further annealing at 37 °C for 10 min. The ﬁnal annealed
products were stored at room temperature. The db DNA units was
evaluated on 3% agarose gel in 0.5× TBE buﬀer at 75 V for 2 h,
stained with SYBR Gold Nucleic acid Gel Stain (Thermo Fisher
Scientiﬁc) (lanes 1 and 2 in Figure 1b).
Fluorescence Microscopy Imaging. The conjugation of the
magnetic microbeads and the DNA capture probe was carried out
using a modiﬁed protocol (Bangs Laboratories) as previously
described.13 Brieﬂy, 1.0 μg of avidin-coated microparticle (5 μm)
suspension was washed with 100 μL of TTL buﬀer (100 mM Tris−
HCl, 0.01% Tween 20, 1 M LiCl, pH 8.0) and resuspended in 10 μL
of TTL. A 1 pmol portion of biotin-modiﬁed capture DNA probe was
then mixed with the resuspended microparticle solution and
incubated at room temperature for 30 min with gentle agitation.
The excess and weakly bound probes were then washed away using
100 μL of TTL buﬀer, TT buﬀer (250 mM Tris-HCl, 0.01% Tween
20, pH 8.0), TTE buﬀer (250 mM Tris−HCl, 0.01% Tween 20, 20
mM Na2(EDTA), pH 8.0), and TT buﬀer after centrifugation at
5000g for 3 min. The capture probe functionalized microparticles
were incubated at 68 °C for 30 min in a prehybridization buﬀer (0.5
M sodium phosphate, 1 mM EDTA, 7% (wt/vol) SDS and 1% (wt/
vol) BSA (pH 8.0)) to functionalize the surface. After removing the
prehybridization buﬀer, the probe-functionalized microparticles were
resuspended and stored in hybridization 1 × SSC buﬀer.
The sample for ﬂuorescence microscopy was prepared by
thoroughly mixing the capture probe functionalized polystyrene
microbeads suspension with target DNA in 50 μL hybridization buﬀer
at room temperature for 30 min to ensure uniform coating.
Subsequently, 5 μL of 1 μM detection probe conjugated with U1
(formed with ssDNA U1−1′ and U1−2) was added into the solution
and incubated at room temperature for 30 min. U1 hybridized onto
microbeads in the presence of target DNA via a sandwiched
hybridization (Figure 2a). The sample was washed three times with
50 μL of hybridization buﬀer to remove excess and weakly bound
detection probe. The U1 immobilized microbeads were then mixed
with formed Cy5-labeled U1 and U2 (5 μL, 0.5 μM) successively and
repeatedly in 20 μL hybridization buﬀer at room temperature for 20
min every time and centrifuged at 5000g for 3 min to remove the
suspension. After that, the microbeads were washed with 50 μL 0.2×
SSC buﬀer ﬁve times to remove excess and weakly bound db DNA
units. The microbeads were concentrated to a ﬁnal concentration of
ca. 5000 beads/mL. A 1 μL portion of the concentrated suspension
was added onto a glass slide. A coverslip was glued onto the glass slide
using nail varnish. For conventional ﬂuorescence microscopy, the
sample was imaged on a Zeiss LSM 800 confocal laser scanning
microscope at 630-fold magniﬁcation using a far-red ﬁlter (Cy5). The
images were analyzed using the ZEN 2.1 lite software. For super-
resolution microscopy (STORM), the samples were imaged using an
ELYRA PS1 microscope (Zeiss), using a 100× Plan-apochromat
objective (NA 1.46 oil immersion). A series of 2000 cycles were
acquired in total internal reﬂection microscopy (TIRF) mode for each
experimental measurements using 642 nm laser (100% power) and
405 nm laser (1% power during integration). For visualization,
“Localization Precision” (20−35 nm) and “Chi Square” (1.5−3)
ﬁlters were used. Images were segmented using CellProﬁler (v2.2.0)27
to identify ﬂuorescent spots and measure shape and intensity.
db DNA-Based ELISA. For db DNA-based ELISA, the
preparation of capture probe coated magnetic microparticles
(MMPs) (Thermo Fisher Scientiﬁc) was carried out as previously
described.14 Brieﬂy, the avidin modiﬁed MMPs (1 μm) were washed
with 100 μL of washing buﬀer (50 Mm Tris−HCl, 150 Mm NaCl,
0.05% Tween 20, pH 8.0) twice. A solution of biotinylated capture
probe was added to the collected MMPs (at a ratio of 2.5 nmol probe
1 to 1 mg MMPs). The mixture was incubated at room temperature
for 20 min with gentle shaking to immobilize the capture probe. The
capture probe coated MMPs were collected using a magnetic
separator, washed three times with washing buﬀer, and resuspended
in blocking solution (10 mM phosphate sodium buﬀer solution, pH
7.4, 100 mM NaCl, 5% PEG and 2% BSA). After incubation at room
temperature for 30 min, the treated MMPs were washed with washing
buﬀer twice and stored in stocking solution (10 mM phosphate
sodium buﬀer solution, pH 7.4, 100 mM NaCl and 1% BSA) at 4 °C
until needed.
The samples for db DNA-based ELISA were prepared by mixing
capture probe functionalized MMPs with target DNA in 50 μL of
hybridization buﬀer (5× SSC, 0.05% Tween 20) at room temperature
for 30 min to ensure uniform coating. A 5 μL portion of 1 μM
detection probe conjugated with U1 (formed with ssDNA U1−1′ and
U1−2) was added into the solution and incubated at room
temperature for 30 min. The sample was washed with 50 μL of
hybridization buﬀer three times to remove excess and weakly bound
Figure 5. Correlation between the copy number of each clinical
sample and the intensity of the signal (absorbance) obtained after
rational 35 cycles of HCR. Dashed red line is a linear ﬁt (R2 = 0.9).
The lowest copy number sample was not detected using rational
HCR (signal below threshold of 0.12).
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detection probe. Then the U1 immobilized MMPs was mixed with U1
and U2 (5 μL, 0.5 μM) successively and repeatedly in 20 μL of
hybridization buﬀer at room temperature for 20 min every time and
collected using a magnetic separator. After addition of the db DNA
units for 20 times in total (the last time was biotin-labeled U2 (5 μL,
1 μM)), MMPs were rinsed with washing buﬀer twice again and
mixed with avidin−horseradish peroxidase (HRP) (Sigma) (20 μg/
mL) in 50 μL of 1× PBS buﬀer for at 37 °C 30 min. After being
rinsed with 50 μL of washing buﬀer seven times to remove the
unbound avidin-HRP, 100 μL of substrate solution containing TMB
(Sigma) was added and mixed thoroughly and the mixture incubated
at room temperature for 10 min before addition of 50 μL of stop
solution (1 M H3PO4, Sigma). The magnetic beads were removed
using a magnetic separator, and the solution was moved to the 96-well
plate for analysis using a microplate reader at 450 nm.
Ethical Statement. All procedures performed in studies involving
human participants were in accordance with the ethical standards of
the institutional and/or national research committee and with the
1964 Helsinki declaration and its later amendments or comparable
ethical standards. All procedures were carried out in accordance with
the “Measures on Ethical Review over Biomedical Research Involving
Human Subjects” (Ministry of Health, China, January 11, 2007). All
the samples were collected from patients after obtaining informed
consent, and the data from these patients were used in this study only.
Clincal Samples. Fifty-four clinical samples were collected in
March 2018 from Adicon Clinical Laboratories (Hangzhou, China).
DNA was extracted from 200 μL of serum using a magnetic beads-
based method according to the provided instructions from the kit
(Sansure Biotech, China). The extracted HBV-DNA was charac-
terized with a quantitative PCR diagnostic kit (Sansure Biotech,
Changsha, China) on an ABI 7500 real-time PCR system (2 min at 95
°C, followed by 45 cycles at 95 °C for 10 s and 60 °C for 30 s).
Positive results were deﬁned according to the instruction supplied.
The sensitivity of the kit is 20 copies per reaction according to the
instructions.
The hybridization process for HBV DNA detection included the
following steps: 200 μL of serum was used for HBV DNA extraction
using the magentic beads, and DNA was eluted with 20 μL of 0.1 TE.
The DNA was then denatured at 95 °C for 5 min to produce single-
strand DNA; the solution was cooled to 50 °C and mixed with 20 μL
of probe-functionalized microparticles for 30 min, followed by two
washes with 50 μL of PBS on a magnetic rack. The detection probe
conjugated with U1 (formed with ssDNA U1−1′ and U1−2) was
added into the solution and incubated at room temperature for 30
min. The hybridization process was repeated for 35 cycles. The data
for each sample are available in the Supporting Information. The
capture probe and detection probe sequences were designed following
previous research.28 The threshold of each individual rational HCR
assay was used to deﬁne the limit of detection with respect to the
negative controls and was established as three standard deviations
above the average signal for all negative samples (0.121).
Extrapolating the linear ﬁt of Figure 5 to that threshold provides a
theoretical limit of detection of three copies, below the experimental
limit, which is between 6 and 14.
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